Clinical trial
Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly…
NCT00045565 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00045565 |
|---|---|
| Title | Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma |
| Official title | Phase I Study of Combined Radiotherapy and Arsenic Trioxide for the Treatment of Newly Diagnosed Malignant Glioma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma |
| Intervention type | Drug, Radiation |
| Interventions | arsenic trioxide, radiation therapy |
| Enrollment | 30 |
| Start date | Oct 1, 2002 |
| Primary completion | Nov 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: